Журнал включен в российские и международные библиотечные и реферативные базы данных
РИНЦ (Россия)
RINZ (RUSSIA)
Регистрационное агентство DOI (США)
DOI Registration Agency (USA)
Эко-Вектор (Россия)
Eco-Vector (Russia)
Ulrichsweb (Ulrich’s Periodicals Director

MANAGEMENT OF CHILDREN WITH A CONCURRENCE OF DIFFERENT PATHOLOGICAL CONDITIONS

DOI: https://doi.org/10.29296/25879979-2019-08-05
Download full text PDF
Issue: 
8
Year: 
2019

Prof. K.I. Grigoryev, MD N.I. Pirogov Russian National Research Medical University, 1, Ostrovityanov St., Moscow 117997, Russian Federation

The paper presents information on the need for care and effective and safe treatment of children, by taking into account the diversity of comorbidities.

Keywords: 
comorbidity
comorbid states
comorbidity in pediatrics



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. rbidnost' pri sindrome gemikonvul'sij- gemiplegii-epilepsii u detej (opisanie 4-h klinicheskih sluchaev). Epilepsija i paroksizmal'nye sostojanija. 2018; 10 (1): 73–9.
  2. Beljalov F. I. Lechenie boleznej v uslovijah komorbidnosti. 10-e izd. M.: GEOTAR-Media, 2016; 544.
  3. Bogmat L.F., Shevchenko H.C., Dem'janenko M.B. Komorbidnost' pri revmaticheskih zabolevanijah u podrostkov: obzor literatury i sobstvennye nabljudenija. Sovremennaja pediatrija. 2015; 2 (66): 56–61.
  4. Vertkin A. L. Komorbidnyj patsient. M.: Eksmo, 2015; 285.
  5. Grigor'ev K.I., Vyhristjuk O.F., Donin I.M., Zavadenko A.N. Sindrom Dauna: komorbidnost' i programmnye tseli v rabote vracha-pediatra s takimi det'mi. Trudnyj patsient. 2017; 15 (1–2): 64–9.
  6. Gudkov R.A., Dmitriev A.V., Fedina N.V. Narushenija nutritivnogo statusa i komorbidnost' u detej. Vestnik RUDN, serija Meditsina, 2016; 1: 54–8.
  7. Zaprudnov A.M., Grigor'ev K.I., Haritonova L.A., Bogomaz L.V., Judina T.M. Problemy i perspektivy izuchenija sovremennoj detskoj gastroenterologii. Pediatrija. 2016; 95 (6): 10–8.
  8. Kamchatnov P.R., Zaharov V.V. Komorbidnyj patsient na ambulatornom prieme. Poliklinika. Nevrologija Revmatologija. Spetsvypusk. 2018; 5: 5–8.
  9. Kats Ja.A., Parhonjuk E.V., Skriptsova S.A. Bolezn' i norma. Monomorbidnost', komorbidnost' i metodologija ih diagnostiki. Saratovskij nauchno-meditsinskij zhurnal. 2018; 14 (2): 209–16.
  10. Lazebnik L.B., Konev Ju.V. Istoricheskie osobennosti i semanticheskie trudnosti ispol'zovanija terminov, oboznachajuschih mnozhestvennost' zabolevanij u odnogo bol'nogo. Eksperimental'naja i klinicheskaja gastroenterologija. 2018; 154 (6): 4–9.
  11. Mazankova L.N., Grigor'ev K.I. Somaticheskie zabolevanija u detej: rol' v vozniknovenii infektsionnoj patologii. Detskie infektsii. 2013; 12 (3): 3–8.
  12. Mutalov A.G. Komorbidnaja patologija v praktike vracha pediatra – osobennosti diagnostiki i taktiki vedenija. Stat'ja opublikovana v «Medvestnike» na portale rossijskogo vracha.
  13. Nenasheva N.M. Bronhial'naja astma. Sovremennyj vzgljad na problemu. M.: GEOTAR-Media, 2018; 304.
  14. Oganov R.G., Simanenkov V.I., Bakulin I.G., Bakulina N.V., Barbarash O.L., Bojtsov S.A., Boldueva S.A., Garganeeva N.P., Doschitsin V.L., Karateev A.E., Kotovskaja Ju.V., Lila A.M., Luk'janov M.M., Morozova T.E. i dr. Komorbidnaja patologija v klinicheskoj praktike. Algoritmy diagnostiki i lechenija: klinicheskie rekomendatsii. Kardiovaskuljarnaja terapija i profilaktika. 2019;18 (1): 5–66.
  15. Pahomova I.G., Horoshinina L.P. NPVS-indutsirovannaja ezofagopatija: prosto GERB ili esche odna nozologicheskaja edinitsa? Farmateka. 2016; 15: 39–43.
  16. Reznichenko Ju.G., Jartseva M.A. Issledovanija transnozologicheskoj komorbidnosti u detej rannego vozrasta v uslovijah bol'shogo promyshlennogo tsentra. Mezhdunarodnyj zhurnal pediatrii, akusherstva i ginekologii. 2014; 5 (1): 48–51.
  17. Schederkina I.O. Disfunktsija zatylochnoj kory i ee komorbidnost' u detej i podrostkov. Avtoref. dis. kand. med. nauk. M., 2011; 24.
  18. Eddy D.M., Adler J., Patterson B. et al. Individualized Guidelines: The Potential for Increasing Quality and Reducing Costs. Ann. Intern. Med. 2011; 154 (9): 627–34.
  19. Marti S., Munoz X., Rios J. et al. Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy. Eur. Respir. J. 2006; 27 (4): 689–96.
  20. Hughes L.D., McMurdo M.E.T., Guthrie B. Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbid- ity. Age Ageing. 2013; 42 (1): 62–9.
  21. Soto-Quiros M„ Avila L., Platts-Mills T.A. et al. High titers of IgE antibody to dust mite allergen and risk for wheezing among asthmatic children infected with rhinovirus. J. Allergy Clin. Immunol. 2012; 129 (№ 6): 1499–505.
  22. Struijs J.N., Baan S.A., Schellevis F.G. et al. Comorbidity in patients with diabetes mellitus: impact on medical health care utilization. BMC Health Serv Res. 2006; 6: 84.
  23. Van den Akker M., Buntinx F., Roos S., Knottnerus J.A. Comorbidity or multimorbidity: what’s in a name? A review.